Shares of Spectral Medical Inc. (TSE:EDT - Get Free Report) crossed below its 50 day moving average during trading on Tuesday . The stock has a 50 day moving average of C$0.62 and traded as low as C$0.57. Spectral Medical shares last traded at C$0.57, with a volume of 130,006 shares traded.
Spectral Medical Stock Performance
The company has a market cap of C$160.31 million, a P/E ratio of -8.14 and a beta of 0.96. The company has a quick ratio of 0.45, a current ratio of 0.61 and a debt-to-equity ratio of 26.03. The business has a fifty day moving average price of C$0.62 and a 200-day moving average price of C$0.55.
Spectral Medical (TSE:EDT - Get Free Report) last issued its quarterly earnings data on Friday, August 9th. The company reported C($0.02) EPS for the quarter. The business had revenue of C$0.47 million during the quarter. On average, analysts forecast that Spectral Medical Inc. will post -0.05 earnings per share for the current year.
Insiders Place Their Bets
In other Spectral Medical news, Director Paul M. Walker sold 150,000 shares of Spectral Medical stock in a transaction dated Friday, September 13th. The stock was sold at an average price of C$0.65, for a total value of C$97,500.00. Corporate insiders own 18.18% of the company's stock.
Spectral Medical Company Profile
(
Get Free Report)
Spectral Medical Inc focuses on the development and commercialization of products for the treatment of septic shock in the United States, Italy, Ireland, and internationally. The company markets Endotoxin Activity Assay, a rapid in vitro diagnostic test for the detection of components of gram negative bacterial cell wall; and Polymyxin B Hemoperfusion, a therapeutic hemoperfusion device that removes endotoxin from the bloodstream.
Recommended Stories
Before you consider Spectral Medical, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Spectral Medical wasn't on the list.
While Spectral Medical currently has a "Hold" rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
MarketBeat just released its list of 10 cheap stocks that have been overlooked by the market and may be seriously undervalued. Click the link below to see which companies made the list.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
